About Excelra Knowledge Solutions Private Limited
Data last updated: 17 December 2025
Excelra Knowledge Solutions Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 24 February 2006, the company has been in operation for over 20 years.
Registered with ROC Hyderabad under CIN U73100AP2006PTC049287.
Capital: an authorised share capital of ₹56.67 Cr and a paid-up capital of ₹56.66 Cr. Formerly known as Gvk Davix Research Services Pvt Ltd. It is led by directors including Venkata Sanjayreddy Gunupati and Anandbir Singh Brar.
Last AGM: 18 July 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹305.69 Cr, a decline of 1% compared to the previous year.
The company has a workforce of approximately 622 employees as per the latest available data.
The company is associated with 2 brands - Gobiom Biomarker, Excelra. As per MCA filings, the company has open charges of ₹66.46 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website excelra.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered Address7Th Floor Wing B Nsl Sez Arena Plot No. 6, Survey No.1 Ida Uppal, Hyderabad, Telangana, India – 500039
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Excelra Knowledge Solutions Private Limited
Excelra Knowledge Solutions Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U72100TG2006PTC049287, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72100TG2006PTC049287 | Current |
| U73100AP2006PTC049287 | Previous |
| U73100TG2006PTC049287 | Previous |
Associated Brands with Excelra Knowledge Solutions Private Limited
Excelra Knowledge Solutions Private Limited operates two associated brands: GOBIOM Biomarker and Excelra. These brands represent Excelra Knowledge Solutions Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive solutions for biomarker database management and analysis. | gobiomdbplus.com | |
| Bioinformatics platform developed for in silico analysis of drug candidates. | excelra.com |
Competitors & Alternatives of Excelra Knowledge Solutions Private Limited
Brands and companies operating in the same space as Excelra Knowledge Solutions Private Limited include Alector, Lexicon Pharmaceuticals, Sutro Biopharma and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Alector
|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | San Francisco, United States, United States | 2013 |
Lexicon Pharmaceuticals
|
Small molecule drugs for various therapeutic areas are developed. | United States | 1995 |
Sutro Biopharma
|
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | United States | 2003 |
Synthego
|
CRISPR-engineered cell and gene therapies are developed for research applications. | Redwood City, United States, United States | 2012 |
Avidity Biosciences
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
Maze Therapeutics
|
Genetic biomarkers are developed for neurological, metabolic, and renal diseases. | Redwood City, United States, United States | 2018 |
Antheia
|
Yeast cells are genetically engineered to produce medicinal products. | Palo Alto, United States, United States | 2013 |
Metabolon
|
Solutions for biomarker discovery and diagnostic testing are provided. | Morrisville, United States, United States | 2000 |
Vividion Therapeutics
|
Developing novel drugs based on a proteome-wide ligand and target discovery platform | Oceanside, United States, United States | 2016 |
Korro Bio
|
RNA-editing technologies are provided for precision medicine applications. | Cambridge, United States, United States | 2018 |
Business Activity of Excelra Knowledge Solutions Private Limited
Excelra Knowledge Solutions Private Limited is engaged in the principal business activity of information and communication, with detailed activities including data processing, hosting and related activities; web portal.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| J | Information and communication | J7 | Data processing, hosting and related activities; web portal | ********* |
Board of Directors of Excelra Knowledge Solutions Private Limited
Excelra Knowledge Solutions Private Limited is currently managed by 6 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Sanjayreddy Gunupati | Director | 24 Feb 2006 | 20 Years 4 Months | Current |
| Anandbir Singh Brar | Director | 16 Jun 2022 | 4 Years 0 Months | Current |
|
Davinder Singh Brar
Also directs:
Epl Limited, Mountain Trail Foods Private Limited, Madhubani Investments Private Limited and 5 more
|
Director | 24 Feb 2006 | 20 Years 4 Months | Current |
|
Sudip Nandy
Also directs:
Redington Limited, Artison Agrotech Private Limited, Spr Emf Innovations Private Limited and 5 more
|
Director | 16 Jun 2022 | 4 Years 0 Months | Current |
|
Sidharth Indukuri Reddy
Also directs:
Heenal Construction Llp, Indukuri Urban Farmery Llp, Indukuri Lifespaces Llp and 5 more
|
Director | 16 Jun 2022 | 4 Years 0 Months | Current |
Financials of Excelra Knowledge Solutions Private Limited FY 2025 filings available
Excelra Knowledge Solutions Private Limited reported revenue of ₹305.69 Cr (down 1% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Excelra Knowledge Solutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2024 | Others | ₹41.46 Cr | Open |
| 01 May 2024 | Citi Bank N.A. | ₹25 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Excelra Knowledge Solutions Private Limited
View historical data on people associated with Excelra Knowledge Solutions Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Excelra Knowledge Solutions Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Excelra Knowledge Solutions Private Limited
GSTIN & GST Filing Data of Excelra Knowledge Solutions Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Excelra Knowledge Solutions Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Excelra Knowledge Solutions Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Excelra Knowledge Solutions Private Limited
MSME Payment Delays by Excelra Knowledge Solutions Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Excelra Knowledge Solutions Private Limited
Subsidiaries & Group Companies of Excelra Knowledge Solutions Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Excelra Knowledge Solutions Private Limited with ownership details.
MCA Filings & Documents of Excelra Knowledge Solutions Private Limited
MCA Filings & Documents of Excelra Knowledge Solutions Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Excelra Knowledge Solutions Private Limited
Recent News on Excelra Knowledge Solutions Private Limited
Frequently Asked Questions about Excelra Knowledge Solutions Private Limited
Excelra Knowledge Solutions Private Limited is an active private limited company in the life sciences sector based in Hyderabad, Telangana, India. It was incorporated on 24 February 2006 (20+ years old) and is registered under CIN U72100TG2006PTC049287. The company has 622 employees.
Excelra Knowledge Solutions Private Limited reported revenue of ₹305.69 Cr for FY 2025 (down 1.00% YoY).
The current directors of Excelra Knowledge Solutions Private Limited are:
The primary industry of Excelra Knowledge Solutions Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Excelra Knowledge Solutions Private Limited can be reached at the registered office: 7Th Floor Wing B Nsl Sez Arena Plot No. 6, Survey No.1 Ida Uppal, Hyderabad, Telangana, India – 500039, or through the website excelra.com.
The authorised capital is ₹56.67 Cr, and the paid-up capital is ₹56.66 Cr.